Patient-reported outcomes and different approaches to urinary parameters in overactive bladder: what should we measure? - Wikidata - awgldk - TriplyDB

Patient-reported outcomes and different approaches to urinary parameters in overactive bladder: what should we measure?

Patient-reported outcomes and different approaches to urinary parameters in overactive bladder: what should we measure?

http://www.wikidata.org/entity/Q37947438

about

The effect of mirabegron on patient-related outcomes in patients with overactive bladder: the results of post hoc correlation and responder analyses using pooled data from three randomized Phase III trials The impact of chronic disease on orphans' quality of life living in extended social care services: a cross sectional analysis.Overactive bladder after female genital mutilation/cutting (FGM/C) type III The Effects of Suburethral Tape on the Symptoms of Overactive Bladder.Symptom score change and patient versus doctor satisfaction in overactive bladder before and after anti-muscarinic treatment.Depressive symptoms and treatment of women with urgency urinary incontinence.Development of a core set of outcome measures for OAB treatment.The multidimensional sensation of desire to void differs between people with and without overactive bladder.Reliability and validity of urinary nerve growth factor measurement in women with lower urinary tract symptoms.

P2860

Q30894093-00AC0E90-A924-4CF6-9450-FC3ABEBD9E6F Q36765356-EFDF72DC-22CF-4743-B28F-33208F73069B Q37293152-4ABDA9E7-7352-47ED-92CB-8267DB5BCF65 Q37660613-88F9221E-6918-425A-AF26-3627EED878B3 Q40263820-4CAB23E3-2243-47ED-A45F-70980E4DDF7A Q44056703-26FB543A-F41E-40AA-A828-1F1C017C6671 Q47095229-7BD25C45-6EC9-4369-A3BE-6DD1AB37CE7C Q48325364-6ABE3A68-0CD6-4D57-94AA-2CFDAA73993F Q50574977-2E65414B-078F-48CA-B65B-B7551925EB27

P2860

Patient-reported outcomes and different approaches to urinary parameters in overactive bladder: what should we measure?

http://www.wikidata.org/entity/Q37947438

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Patient-reported outcomes and ...... adder: what should we measure?

@en

Patient-reported outcomes and ...... adder: what should we measure?

@nl

type

label

Patient-reported outcomes and ...... adder: what should we measure?

@en

Patient-reported outcomes and ...... adder: what should we measure?

@nl

prefLabel

Patient-reported outcomes and ...... adder: what should we measure?

@en

Patient-reported outcomes and ...... adder: what should we measure?

@nl

P1433

Q37947438-30826397-63EA-4E2B-A340-53E8838329EB

P1476

Q37947438-003D53B0-161D-44A9-BBC8-1D2E8C965581

P2093

Q37947438-5634E293-ACC5-4775-9C94-170A8EA710A1

P2860

Q37947438-01B5908F-021F-473D-9E53-19D556BA30A3

Q37947438-03F3127D-232D-4CE4-A335-5E409EAC2629

Q37947438-06805629-3FA4-45E3-ACD1-A27996CAA863

Q37947438-134570DB-EC90-4BA0-BA9F-2373A72734EE

Q37947438-1AA2A73C-B9A0-495E-AF69-F0614E3757DA

Q37947438-1AF79343-8032-43ED-B9FF-F7C101EC2040

Q37947438-204B9B30-E87C-4968-99BC-FB6850EA257E

Q37947438-2730059F-09AE-4E7F-B566-AD814CA00F8C

Q37947438-2963D03C-7994-4C76-849F-00A3DA47185E

Q37947438-2E71214F-C1D9-4A13-B019-8ECE49615CB4

P2888

Q37947438-4D03191B-D570-4F47-82A6-84D9AA3A0267

P304

Q37947438-B13AE52F-D96B-4D3E-97F6-39FEE9690EBF

P31

Q37947438-0973063D-59B3-4149-9B48-A0A1992B4C5D

P356

Q37947438-39F33827-09D1-481E-A2EF-6F66231D4C89

P433

Q37947438-5C204520-1ED5-43F8-AB23-25DB8945FA0E

P478

Q37947438-7051B40F-038D-4426-AC2D-676BF3ED6366

P577

Q37947438-6791A8F4-8E24-4BFD-8386-6D3565D4B49A

P698

Q37947438-CACE01D4-995D-42FE-A8C9-B1FA50F1037D

P921

Q37947438-60EFD1E7-FEEF-4414-99E4-001F3917E61D

P356

S00192-011-1526-9

P1433

International Urogynecology Journal and Pelvic Floor Dysfunction

P1476

Patient-reported outcomes and ...... adder: what should we measure?

@en

P2093

Vik Khullar

http://www.w3.org/2001/XMLSchema#string

P2860

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

Development and validation of a quality-of-life measure for men with nocturia

Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence

Disease burden of overactive bladder: quality-of-life data assessed using ICI-recommended instruments.

Prevalence, evaluation and management of overactive bladder in primary care

The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies.

Clinical relevance of health-related quality of life outcomes with darifenacin.

Future studies of overactive bladder: the need for standardization.

Assessment of an electronic daily diary in patients with overactive bladder.

P2888

s00192-011-1526-9

P304

179-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00192-011-1526-9

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22011932

http://www.w3.org/2001/XMLSchema#string

P921